130 related articles for article (PubMed ID: 37337282)
1. Scutellaria baicalensis enhances 5-fluorouracil-based chemotherapy via inhibition of proliferative signaling pathways.
Liu H; Liu H; Zhou Z; Chung J; Zhang G; Chang J; Parise RA; Chu E; Schmitz JC
Cell Commun Signal; 2023 Jun; 21(1):147. PubMed ID: 37337282
[TBL] [Abstract][Full Text] [Related]
2. Herbal formula Huang Qin Ge Gen Tang enhances 5-fluorouracil antitumor activity through modulation of the E2F1/TS pathway.
Liu H; Liu H; Zhou Z; Parise RA; Chu E; Schmitz JC
Cell Commun Signal; 2018 Feb; 16(1):7. PubMed ID: 29458395
[TBL] [Abstract][Full Text] [Related]
3. Baicalin; a promising chemopreventive agent, enhances the antitumor effect of 5-FU against breast cancer and inhibits tumor growth and angiogenesis in Ehrlich solid tumor.
Shehatta NH; Okda TM; Omran GA; Abd-Alhaseeb MM
Biomed Pharmacother; 2022 Feb; 146():112599. PubMed ID: 34968922
[TBL] [Abstract][Full Text] [Related]
4. Hydrophobic flavonoids from Scutellaria baicalensis induce colorectal cancer cell apoptosis through a mitochondrial-mediated pathway.
Wang CZ; Calway TD; Wen XD; Smith J; Yu C; Wang Y; Mehendale SR; Yuan CS
Int J Oncol; 2013 Mar; 42(3):1018-26. PubMed ID: 23337959
[TBL] [Abstract][Full Text] [Related]
5. Low curcumin concentration enhances the anticancer effect of 5-fluorouracil against colorectal cancer.
Zheng X; Yang X; Lin J; Song F; Shao Y
Phytomedicine; 2021 May; 85():153547. PubMed ID: 33812170
[TBL] [Abstract][Full Text] [Related]
6. Esculetin enhances the inhibitory effect of 5-Fluorouracil on the proliferation, migration and epithelial-mesenchymal transition of colorectal cancer.
Yan L; Yu HH; Liu YS; Wang YS; Zhao WH
Cancer Biomark; 2019; 24(2):231-240. PubMed ID: 30689555
[TBL] [Abstract][Full Text] [Related]
7. Baicalin, the major component of traditional Chinese medicine Scutellaria baicalensis induces colon cancer cell apoptosis through inhibition of oncomiRNAs.
Tao Y; Zhan S; Wang Y; Zhou G; Liang H; Chen X; Shen H
Sci Rep; 2018 Sep; 8(1):14477. PubMed ID: 30262902
[TBL] [Abstract][Full Text] [Related]
8. The combined anti-tumor effects of 5-fluorouracil and neurokinin receptor inhibitor, aprepitant, against colorectal cancer: In vitro and in vivo study.
Alalikhan A; Ebrahimi S; Aliee A; Mirzavi F; Hashemy SI
Med Oncol; 2024 Feb; 41(3):70. PubMed ID: 38340190
[TBL] [Abstract][Full Text] [Related]
9. Sanguisorba officinalis L. suppresses 5-fluorouracil-sensitive and-resistant colorectal cancer growth and metastasis via inhibition of the Wnt/β-catenin pathway.
Zhang W; Peng C; Yan J; Chen P; Jiang C; Sang S; Yuan Y; Hong Y; Yao M
Phytomedicine; 2022 Jan; 94():153844. PubMed ID: 34785413
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-375-3p enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer.
Xu F; Ye ML; Zhang YP; Li WJ; Li MT; Wang HZ; Qiu X; Xu Y; Yin JW; Hu Q; Wei WH; Chang Y; Liu L; Zhao Q
Cancer Sci; 2020 May; 111(5):1528-1541. PubMed ID: 32073706
[TBL] [Abstract][Full Text] [Related]
11. Pseudolaric acid B induces mitotic arrest and apoptosis in both 5-fluorouracil-sensitive and -resistant colorectal cancer cells.
Wen C; Chen J; Zhang D; Wang H; Che J; Qin Q; He L; Cai Z; Lin M; Lou Q; Huang L; Chen D; Iwamoto A; Ren D; Wang L; Lan P; Wang J; Liu H; Yang X
Cancer Lett; 2016 Dec; 383(2):295-308. PubMed ID: 27713084
[TBL] [Abstract][Full Text] [Related]
12. Combined 5-FU and ChoKα inhibitors as a new alternative therapy of colorectal cancer: evidence in human tumor-derived cell lines and mouse xenografts.
de la Cueva A; Ramírez de Molina A; Alvarez-Ayerza N; Ramos MA; Cebrián A; Del Pulgar TG; Lacal JC
PLoS One; 2013; 8(6):e64961. PubMed ID: 23762272
[TBL] [Abstract][Full Text] [Related]
13. Enalapril overcomes chemoresistance and potentiates antitumor efficacy of 5-FU in colorectal cancer by suppressing proliferation, angiogenesis, and NF-κB/STAT3-regulated proteins.
Yang Y; Ma L; Xu Y; Liu Y; Li W; Cai J; Zhang Y
Cell Death Dis; 2020 Jun; 11(6):477. PubMed ID: 32581212
[TBL] [Abstract][Full Text] [Related]
14. Syndecan-2, negatively regulated by miR-20b-5p, contributes to 5-fluorouracil resistance of colorectal cancer cells via the JNK/ERK signaling pathway.
Hua R; Zhang Y; Yan X; Tang D; Li X; Ni Q; Wang D; Zhu J
Acta Biochim Biophys Sin (Shanghai); 2021 Nov; 53(11):1547-1557. PubMed ID: 34596215
[TBL] [Abstract][Full Text] [Related]
15. A novel strategy for active compound efficacy status identification in multi-tropism Chinese herbal medicine (Scutellaria baicalensis Georgi) based on multi-indexes spectrum-effect gray correlation analysis.
Deng X; Lei HY; Ren YS; Ai J; Li YQ; Liang S; Chen LL; Liao MC
J Ethnopharmacol; 2023 Jan; 300():115677. PubMed ID: 36064148
[TBL] [Abstract][Full Text] [Related]
16. A Bioactive Compound from
Zhang W; Peng C; Shen X; Yuan Y; Zhang W; Yang C; Yao M
Molecules; 2021 Jun; 26(13):. PubMed ID: 34202548
[TBL] [Abstract][Full Text] [Related]
17. ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer.
Dong S; Liang S; Cheng Z; Zhang X; Luo L; Li L; Zhang W; Li S; Xu Q; Zhong M; Zhu J; Zhang G; Hu S
J Exp Clin Cancer Res; 2022 Jan; 41(1):15. PubMed ID: 34998404
[TBL] [Abstract][Full Text] [Related]
18. Curcumin enhances the effect of chemotherapy against colorectal cancer cells by inhibition of NF-κB and Src protein kinase signaling pathways.
Shakibaei M; Mobasheri A; Lueders C; Busch F; Shayan P; Goel A
PLoS One; 2013; 8(2):e57218. PubMed ID: 23451189
[TBL] [Abstract][Full Text] [Related]
19. Synergistic antitumor activity of 5-fluorouracil and atosiban against microsatellite stable colorectal cancer through restoring GATA3.
Wang M; Guo X; Yang M; Zhang Y; Meng F; Chen Y; Chen M; Qiu T; Li J; Li Z; Zhang Q; Xu F; Zhang H; Wang W
Biochem Pharmacol; 2022 May; 199():115025. PubMed ID: 35367196
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L
Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
